Department of Psychosis Studies,Institute of Psychiatry, Psychology & Neuroscience,King's College London,London,UK.
Acta Neuropsychiatr. 2018 Feb;30(1):43-57. doi: 10.1017/neu.2016.58. Epub 2016 Nov 21.
The relationship between cannabis use and the onset of psychosis is well established. Aberrant salience processing is widely thought to underpin many of these symptoms. Literature explicitly investigating the relationship between aberrant salience processing and cannabis use is scarce; with those few studies finding that acute tetrahydrocannabinol (THC) administration (the main psychoactive component of cannabis) can result in abnormal salience processing in healthy cohorts, mirroring that observed in psychosis. Nevertheless, the extent of and mechanisms through which cannabis has a modulatory effect on aberrant salience, following both acute and chronic use, remain unclear.
Here, we systematically review recent findings on the effects of cannabis use - either through acute THC administration or in chronic users - on brain regions associated with salience processing (through functional MRI data); and performance in cognitive tasks that could be used as either direct or indirect measures of salience processing. We identified 13 studies either directly or indirectly exploring salience processing. Three types of salience were identified and discussed - incentive/motivational, emotional/affective, and attentional salience.
The results demonstrated an impairment of immediate salience processing, following acute THC administration. Amongst the long-term cannabis users, normal salience performance appeared to be underpinned by abnormal neural processes.
Overall, the lack of research specifically exploring the effects of cannabis use on salience processing, weaken any conclusions drawn. Additional research explicitly focussed on salience processing and cannabis use is required to advance our understanding of the neurocognitive mechanisms underlying the association between cannabis use and development of psychosis.
大麻使用与精神病发病之间的关系已得到充分证实。异常突显处理被广泛认为是这些症状的基础。专门研究异常突显处理与大麻使用之间关系的文献很少;少数研究发现,急性四氢大麻酚(THC)给药(大麻的主要精神活性成分)可导致健康队列中异常突显处理,与精神病中观察到的情况相似。然而,大麻在急性和慢性使用后对异常突显的调节作用的程度和机制仍不清楚。
在这里,我们系统地回顾了最近关于大麻使用(通过急性 THC 给药或慢性使用者)对与突显处理相关的大脑区域的影响的研究结果(通过功能磁共振成像数据);以及在认知任务中的表现,这些任务可以作为突显处理的直接或间接测量。我们确定了 13 项直接或间接地探索突显处理的研究。确定并讨论了三种类型的突显处理 - 激励/动机、情感/情感和注意力突显处理。
结果表明,急性 THC 给药后,即时突显处理受损。在长期大麻使用者中,正常突显处理似乎是由异常的神经过程支撑的。
总体而言,缺乏专门研究大麻使用对突显处理影响的研究,削弱了得出的任何结论。需要进行更多专门研究突显处理和大麻使用的研究,以深入了解大麻使用与精神病发病之间关联的神经认知机制。